PCMA: Biotech Manufacturers Lobby States to Restrict Access to Biosimilar Medications
January 31, 2013
(Washington, DC)— Some biotech drug manufacturers are lobbying state legislators to restrict access to biosimilar (or biogeneric) versions of...
PCMA: Biotech Manufacturers Lobby States to Restrict Access to Biosimilar Medications
January 31, 2013
(Washington, DC)— Some biotech drug manufacturers are lobbying state legislators to restrict access to biosimilar (or biogeneric) versions of...